| ISIN | CH1238288042 |
|---|---|
| Valor Number | 123828804 |
| Bloomberg Global ID | SYNSWSI SW |
| Fund Name | SYNCHRONY MARKET FUNDS - Synchrony Swiss Equity I |
| Fund Provider |
Banque Cantonale de Genève
Genève, Switzerland Phone: +41 58 211 21 11 E-Mail: info@bcge.ch Web: www.bcge.ch |
| Fund Provider | Banque Cantonale de Genève |
| Representative in Switzerland | |
| Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The objective of the Synchrony Swiss Equity Subfund is long term capital growth by investing in shares of the Swiss companies that make up the SPI® index. Companies are identified and selected based on their fundamentals, using a systematic stock-picking methodology. The Subfund invests at least two-thirds of its assets in shares and other securities or participation rights of companies domiciled or having a predominant amount of their business activity in Switzerland, and which are part of the SPI® index. |
| Peculiarities |
| Current Price * | 111.36 CHF | 08.01.2026 |
|---|---|---|
| Previous Price * | 111.36 CHF | 07.01.2026 |
| 52 Week High * | 111.36 CHF | 07.01.2026 |
| 52 Week Low * | 90.94 CHF | 09.04.2025 |
| NAV * | 111.36 CHF | 08.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 163,787,427 | |
| Unit/Share Assets *** | 103,862,520 | |
| Trading Information SIX | ||
| YTD Performance | +1.07% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
|---|---|---|
| 1 month | +2.61% |
08.12.2025 - 08.01.2026
08.12.2025 08.01.2026 |
| 3 months | +4.18% |
08.10.2025 - 08.01.2026
08.10.2025 08.01.2026 |
| 6 months | +8.13% |
08.07.2025 - 08.01.2026
08.07.2025 08.01.2026 |
| 1 year | +10.56% |
08.01.2025 - 08.01.2026
08.01.2025 08.01.2026 |
| 2 years | +17.29% |
14.02.2024 - 08.01.2026
14.02.2024 08.01.2026 |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 11.59% | |
|---|---|---|
| Nestle SA | 10.94% | |
| Roche Holding AG | 10.68% | |
| ABB Ltd | 6.71% | |
| UBS Group AG Registered Shares | 6.31% | |
| Zurich Insurance Group AG | 5.15% | |
| Compagnie Financiere Richemont SA Class A | 4.79% | |
| Lonza Group Ltd | 3.24% | |
| Swiss Re AG | 3.05% | |
| Sika AG | 2.80% | |
| Last data update | 30.09.2025 | |
| TER | 0.62% |
|---|---|
| TER date | 15.09.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.75% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |